Metabolic syndrome and prostate cancer risk in a population-based case–control study in Montreal, Canada

BMC Public Health

Table 1 Criteria, case–control distribution and association between MetS and PCa, according to different MetS definitions

MetS Definition	Criteria used in the study	Cases (N = 1937)		Controls (N = 1995)		OR^a	CI 95 %
MetS Definition	Criteria used in the study	N	%	n	%	OR^a	CI 95 %
NCEP-ATPIII	At least 3 of these conditions:	476	24.9	629	31.8	0.70	0.60-0.82
	- Dyslipidemia (counting for 2 conditions: low HDL-C and high TG)
	- Type 2 diabetes
	- Hypertension
	- WC > 102 cm (or BMI > 30)
NCEP-ATPIII ico	NCEP-ATPIII criteria with waist-to-height ratio > 0.5 instead of WC > 102 cm	579	30.3	734	37.2	0.71	0.61-0.82
WHO	Type 2 diabetes + 2 other conditions among them:	149	7.8	279	14.1	0.54	0.44-0.68
	- Hypertension
	- BMI > 30 or waist-to-hip ratio > 0.9
	- Dyslipidemia (as a simple condition)
IDF	- WC > 90 cm for Asiatic men and > 94 cm for others (or BMI > 30) + 2 other conditions among them:	427	22.3	527	26.6	0.75	0.64-0.88
	- Type 2 diabetes
	- Hypertension
	- Dyslipidemia (counting for 2 conditions: low HDL-C and high TG)

^aAdjusted for age, family history of prostate cancer, ancestry, prostate cancer screening and family income.BMI, Body mass index; CI, Confidence interval; HDL-C, High-density lipoprotein cholesterol; IDF, International Diabetes Federation; NCEP-ATPIII, Adult Treatment Panel III from the National Cholesterol Education Program; OR, Odds ratio; TG: Triglycerides; WC, Waist circumference; WHO: World Health Organization

ISSN: 1471-2458